News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
393,771 Results
Type
Article (26324)
Company Profile (60)
Press Release (367385)
Multimedia
Podcasts (34)
Webinars (7)
Section
Business (104371)
Career Advice (455)
Deals (16887)
Drug Delivery (53)
Drug Development (47731)
Employer Resources (47)
FDA (12346)
Job Trends (8482)
News (186331)
Policy (19522)
Tag
2027 Biotech Bay Standard (1)
2027 Pharm Country Standard (1)
Academia (1757)
Accelerated approval (14)
Adcomms (10)
Allergies (110)
Alliances (26825)
ALS (95)
Alzheimer's disease (972)
Antibody-drug conjugate (ADC) (161)
Approvals (12679)
Artificial intelligence (302)
Autoimmune disease (89)
Automation (8)
Bankruptcy (142)
Best Places to Work (6891)
BIOSECURE Act (5)
Biosimilars (73)
Biotechnology (40)
Bladder cancer (124)
Brain cancer (36)
Breast cancer (414)
Cancer (3059)
Cardiovascular disease (265)
Career advice (416)
Career pathing (15)
CAR-T (133)
CDC (26)
Celiac Disease (2)
Cell therapy (363)
Cervical cancer (26)
Clinical research (42931)
Collaboration (849)
Compensation (271)
Complete response letters (16)
COVID-19 (1553)
CRISPR (35)
C-suite (484)
Cystic fibrosis (59)
Data (4220)
Decentralized trials (2)
Denatured (20)
Depression (93)
Diabetes (316)
Diagnostics (3712)
Digital health (28)
Diversity (7)
Diversity, equity & inclusion (13)
Drug discovery (94)
Drug pricing (91)
Drug shortages (22)
Duchenne muscular dystrophy (123)
Earnings (38611)
Editorial (28)
Employer branding (6)
Employer resources (46)
Events (54181)
Executive appointments (584)
FDA (14619)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (5)
Frontotemporal dementia (10)
Funding (750)
Gene editing (75)
Generative AI (20)
Gene therapy (258)
GLP-1 (541)
Government (3142)
Grass and pollen (4)
Guidances (229)
Healthcare (12210)
HIV (38)
Huntington's disease (20)
IgA nephropathy (50)
Immunology and inflammation (81)
Immuno-oncology (25)
Indications (67)
Infectious disease (1684)
Inflammatory bowel disease (109)
Inflation Reduction Act (7)
Influenza (51)
Intellectual property (118)
Interviews (40)
IPO (7072)
IRA (23)
Job creations (1845)
Job search strategy (381)
JPM (18)
Kidney cancer (10)
Labor market (34)
Layoffs (194)
Leadership (8)
Legal (3646)
Liver cancer (66)
Longevity (7)
Lung cancer (481)
Lymphoma (249)
Machine learning (16)
Management (17)
Manufacturing (288)
MASH (105)
Medical device (13296)
Medtech (13341)
Mergers & acquisitions (10326)
Metabolic disorders (750)
Multiple sclerosis (96)
NASH (11)
Neurodegenerative disease (160)
Neuropsychiatric disorders (42)
Neuroscience (1687)
NextGen: Class of 2026 (3933)
Non-profit (2835)
Now hiring (33)
Obesity (310)
Opinion (95)
Ovarian cancer (119)
Pain (140)
Pancreatic cancer (140)
Parkinson's disease (164)
Partnered (17)
Patents (224)
Patient recruitment (349)
Peanut (42)
People (35634)
Pharmaceutical (15)
Pharmacy benefit managers (16)
Phase 1 (12337)
Phase 2 (18566)
Phase 3 (15261)
Pipeline (3023)
Policy (125)
Postmarket research (1668)
Preclinical (3799)
Press Release (18)
Prostate cancer (177)
Psychedelics (26)
Radiopharmaceuticals (177)
Rare diseases (425)
Real estate (2869)
Recruiting (18)
Regulatory (15680)
Reports (18)
Research institute (1653)
Resumes & cover letters (49)
Rett syndrome (16)
RNA editing (5)
RSV (39)
Schizophrenia (113)
Series A (116)
Series B (93)
Service/supplier (2)
Sickle cell disease (45)
Special edition (6)
Spinal muscular atrophy (104)
Sponsored (16)
Startups (2133)
Stomach cancer (11)
Supply chain (60)
Tariffs (25)
The Weekly (14)
Vaccines (502)
Venture capital (27)
Weight loss (209)
Women's health (54)
Worklife (4)
Date
Last 7 days (303)
Last 30 days (1099)
Last 365 days (16121)
2026 (1471)
2025 (16467)
2024 (19847)
2023 (22739)
2022 (30681)
2021 (32987)
2020 (32194)
2019 (28415)
2018 (21811)
2017 (18907)
2016 (18111)
2015 (21194)
2014 (16024)
2013 (13241)
2012 (14350)
2011 (14623)
2010 (13184)
Location
Africa (367)
Alabama (30)
Alaska (2)
Arizona (174)
Arkansas (10)
Asia (25485)
Australia (4029)
California (5566)
Canada (1903)
China (782)
Colorado (285)
Connecticut (284)
Delaware (249)
Europe (49886)
Florida (949)
Georgia (225)
Hawaii (1)
Idaho (35)
Illinois (577)
India (32)
Indiana (376)
Iowa (11)
Japan (314)
Kansas (90)
Kentucky (19)
Louisiana (18)
Maine (28)
Maryland (890)
Massachusetts (3734)
Michigan (149)
Minnesota (442)
Mississippi (5)
Missouri (78)
Montana (19)
Nebraska (21)
Nevada (65)
New Hampshire (73)
New Jersey (1921)
New Mexico (10)
New York (1562)
North Carolina (810)
North Dakota (4)
Northern California (2643)
Ohio (212)
Oklahoma (8)
Oregon (28)
Pennsylvania (1347)
Puerto Rico (11)
Rhode Island (35)
South America (524)
South Carolina (59)
Southern California (2234)
Tennessee (124)
Texas (1017)
United States (21591)
Utah (194)
Virginia (141)
Washington D.C. (52)
Washington State (384)
West Virginia (4)
Wisconsin (71)
Wyoming (1)
393,771 Results for "setpoint medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Rush University Medical Center Performs First SetPoint System Procedures in Chicago for Treatment of Rheumatoid Arthritis
February 4, 2026
·
3 min read
Press Releases
SetPoint Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 16, 2025
·
1 min read
Press Releases
SetPoint Medical to Present Data at ACR Convergence 2025 Demonstrating Sustained Efficacy and Safety for the SetPoint System to Treat Rheumatoid Arthritis
October 27, 2025
·
9 min read
Press Releases
Landmark RESET-RA Study Published in Nature Medicine Demonstrates Durable Efficacy and Safety of the SetPoint System for Rheumatoid Arthritis
January 5, 2026
·
4 min read
Press Releases
SetPoint Medical Receives FDA Approval for Novel Neuroimmune Modulation Therapy for Rheumatoid Arthritis
July 31, 2025
·
4 min read
Press Releases
SetPoint Medical Appoints Tyler Binney to Its Board of Directors
June 4, 2025
·
2 min read
Press Releases
SetPoint Medical Receives Clinical Research Award at EULAR 2025 Congress
June 11, 2025
·
2 min read
Press Releases
SetPoint Medical Raises $140 Million in Private Financing and Expands Leadership Team to Support Commercialization of Rheumatoid Arthritis Therapy
August 12, 2025
·
3 min read
Press Releases
Northwell Health Implants Nation’s First Patient with SetPoint System for Treatment of Rheumatoid Arthritis
August 26, 2025
·
5 min read
FDA
SetPoint Medical Receives FDA Breakthrough Device Designation for its Neuroimmune Modulation Platform for the Treatment of Multiple Sclerosis
SetPoint Medical Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for the use of its novel neuroimmune modulation platform for people living with relapsing-remitting multiple sclerosis (RRMS).
March 13, 2024
·
4 min read
1 of 39,378
Next
